Journal
MATURITAS
Volume 109, Issue -, Pages 78-80Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.maturitas.2017.12.015
Keywords
Visnadine; Prenylflavonoids; Bovine colostrum; Vulvovaginal atrophy; Menopause; Sexual wellbeing
Categories
Ask authors/readers for more resources
This single-arm pilot study enrolled 47 post-menopausal women affected by vulvovaginal atrophy (VVA). The Vaginal Health Index Score (VHIS) was evaluated for all women and all completed the Female Sexual Function Index (FSFI) questionnaire at baseline (TO) and after 15 days of vaginal cream treatment with one application per day (T1). Following treatment there was a significant improvement in all VHIS parameters and total score (p < 0.0001). Similarly, there was a significant improvement on four FSFI domains (lubrication, orgasm, satisfaction and pain) and total score (p = 0.001). None of the patients reported any local or systemic side-effects during treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available